Drugs That Affect Blood Coagulation, Fibrinolysis and Hemostasis

Taylor, Michelle E.; Mehmood, Tahir; Kreuter, Justin D.

doi:10.1016/bs.seda.2015.07.011

Side Effects of Drugs Annual

2015

DOI: 10.1016/bs.seda.2015.07.011

|View full text |Cite

Drugs That Affect Blood Coagulation, Fibrinolysis and Hemostasis

Michelle E. Taylor¹,

Tahir Mehmood²,

Justin D. Kreuter³

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 70 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Medicines affecting blood are essentially important in the case of several vascular and systemic diseases and pathophysiological states. [7] The NLEM 2015 has two classes of drugs in the category of "Medicines Affecting Blood, " which is 10.1-antianemia medicines and 10.2-medicines affecting coagulation. And these are important medications that may be taken by people from all walks of life, be it age, gender, occupation, ethnicity, and other sociodemographic facets.…”

mentioning

confidence: 99%

Evaluating the validity of the national list of essential medicines 2015 for medicines affecting blood in 2022: An observational cost analysis

Ahmed¹

2022

JHAS

View full text Add to dashboard Cite

Objectives: The study aims at evaluating the validity of the national list of essential medicines (NLEM) 2015 for medicines affecting blood in 2022. The study essentially aims at conducting a cost analysis that mainly compares the cost variation between the highest and lowest priced branded variants of the same. Material and Methods: The study takes into account the aforementioned two classes of “Medicines Affecting Blood,” which is 10.1–antianemia medicines and 10.2–medicines affecting coagulation. Data were collected from MedGuideIndia, a database of medicines marketed in India. Both cost ratio and percentage cost variations were calculated. Results: Under 10.1–Antianemia medicines, hydroxycobalamin 2 ml injection (500 mcg/1 ml) has the highest percentage cost variation at 1451.72% and folic acid 5 mg tablets have the lowest percentage cost variation at 20.45%. Under 10.2– medicines affecting coagulation, phytomenadione 1 ml injection (10 mg/1 ml) has the highest percentage cost variation at 3784.46% and heparin 2 ml injection (1000 IU) has the lowest percentage cost variation at 10.4%. Conclusion: This study essentially reasons the need for the central drugs standard control organization and NPPI to intervene and appropriately modify the NLEM 2015 and introduce stricter rules and regulations, while ensuring that the appropriate price caps are both enforced and maintained for essential medicines.

show abstract

mentioning

confidence: 99%

Evaluating the validity of the national list of essential medicines 2015 for medicines affecting blood in 2022: An observational cost analysis

Ahmed¹

2022

JHAS

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Drugs That Affect Blood Coagulation, Fibrinolysis and Hemostasis

Cited by 1 publication

References 70 publications

Evaluating the validity of the national list of essential medicines 2015 for medicines affecting blood in 2022: An observational cost analysis

Evaluating the validity of the national list of essential medicines 2015 for medicines affecting blood in 2022: An observational cost analysis

Contact Info

Product

Resources

About